Oscar Health, Inc. (NYSE:OSCR) Q3 2023 Earnings Call Transcript

Josh Raskin: I’ll look for the update. Thank you.

Scott Blackley: Let me just add one thing on C+O. So in the same way that 2023 for our IFP business, we really took a measured approach at trying to drive strong performance. I think in C+O growth rates there have been slower than what we’ve seen in the prior year. And that’s primarily a focus on making sure that we’re disciplined in the way we execute against the marketplace. So continue to be excited about the potential for that business. But I think we’ve really just taken a measured approach at making sure we can create a business and we’re happy with the outcomes.

Operator: And there are no further questions at this time. This concludes today’s conference call. Thank you for your participation. You may now disconnect.